Ep
No verificado

Epirium Bio Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud
05/05/2026
Eventos
Ciencia
Tercera edad
Biotecnología
Farmacéutica
Salud
Ir de compras
Medicina - Varios
Epirium Bio Presenting New Preclinical Data on its 15-PGDH Inhibitor Program in Inflammatory Bowel Disease at Digestive Disease Week® 2026
1.00
12/03/2026
Eventos
Industria
Ciencia
Tercera edad
Medicina - Varios
Biotecnología
Salud
Ir de compras
Farmacéutica
Epirium Bio to Present New MF-300 Clinical and Translational Data at the Intrinsic Capacity, Frailty and Sarcopenia Research Conference 2026
1.00
27/01/2026
Ciencia
Higiene alimentaria
Tercera edad
Medicina - Varios
Biotecnología
Salud
Ir de compras
Farmacéutica
Industria
Epirium Bio Announces Positive Type C (End-of-Phase 1) Meeting with FDA Supporting Advancement of MF-300 to a Phase 2b Clinical Trial in Sarcopenia
1.00
08/01/2026
Ciencia
Tercera edad
Biotecnología
Farmacéutica
Salud
Ir de compras
Medicina - Varios
Industria
Epirium Bio Announces Follow-on Phase 1 Results in Older Adult Participants for MF-300, a First-In-Class, Oral 15-PGDH Enzyme Inhibitor, for the Treatment of Sarcopenia
1.00
13/03/2025
Web y redes sociales
Eventos
Industria
Ciencia
Tercera edad
Biotecnología
Farmacéutica
Salud
Ir de compras
Medicina - Varios
Epirium Bio to Present MF-300 Preclinical Data at the International Conference on Frailty and Sarcopenia Research
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0